|

Trastuzumab Injection Clinical Trials

3 actively recruiting trials

▲ +1 trial since June 2026

Pipeline

Phase 2: 1Phase 3: 1Phase 2/3: 1

Top Sponsors

  • UNICANCER1
  • SUNHO（China）BioPharmaceutical CO., Ltd.1
  • Jiangsu HengRui Medicine Co., Ltd.1

Indications

  • Cancer3
  • Breast Cancer2
  • Leptomeningeal Disease1
  • Early-stage or Locally Advanced HER2-positive Breast Cancer1
  • HER2-positive Metastatic Breast Cancer1

Other3 trials

A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in Early-stage or Locally Advanced HER2-positive Breast Cancer
Phase 3
Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease
Phase 2
To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer
Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.